Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy

Adult Male Coronaviru Hepatiti Pneumonia, Viral 610 Acute respiratory failure Hepatitis 03 medical and health sciences 0302 clinical medicine Patients' Rooms 617 Internal Medicine Humans Pandemics Aged Retrospective Studies Aged, 80 and over COVID-19 Middle Aged Im - Original 3. Good health Coronavirus Hospitalization Severe acute respiratory syndrome Italy Liver Emergency Medicine Female Coronavirus Infections Liver Failure
DOI: 10.1007/s11739-020-02425-w Publication Date: 2020-07-10T09:03:43Z
AUTHORS (98)
ABSTRACT
AbstractLittle is known regarding coronavirus disease 2019 (COVID-19) clinical spectrum in non-Asian populations. We herein describe the impact of COVID-19 on liver function in 100 COVID-19 consecutive patients (median age 70 years, range 25–97; 79 males) who were admitted to our internal medicine unit in March 2020. We retrospectively assessed liver function tests, taking into account demographic characteristics and clinical outcome. A patient was considered as having liver injury when alanine aminotransferase (ALT) was > 50 mU/ml, gamma-glutamyl transpeptidase (GGT) > 50 mU/ml, or total bilirubin > 1.1 mg/dl. Spearman correlation coefficient for laboratory data and bivariable analysis for mortality and/or need for intensive care were assessed. A minority of patients (18.6%) were obese, and most patients were non- or moderate-drinkers (88.5%). Liver function tests were altered in 62.4% of patients, and improved during follow-up. None of the seven patients with known chronic liver disease had liver decompensation. Only one patient developed acute liver failure. In patients with altered liver function tests, PaO2/FiO2 < 200 was associated with greater mortality and need for intensive care (HR 2.34, 95% CI 1.07–5.11,p = 0.033). To conclude, a high prevalence of altered liver function tests was noticed in Italian patients with COVID-19, and this was associated with worse outcomes when developing severe acute respiratory distress syndrome.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (37)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....